O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-1.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.88B
AUM Growth
+$7.88B
(-24%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
148
New
11
Increased
16
Reduced
57
Closed
17
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Amicus Therapeutics
FOLD
|
$80.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$77.8M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$43.5M |
| 5 |
scPharmaceuticals
SCPH
|
$41.2M |
Top Sells
| 1 |
Incyte
INCY
|
$172M |
| 2 |
AET
Aetna Inc
AET
|
$171M |
| 3 |
Biogen
BIIB
|
$127M |
| 4 |
Merck
MRK
|
$105M |
| 5 |
Gilead Sciences
GILD
|
$101M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 1.43% |
